Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

Advertising by Adpathway

Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma

1 day ago 14

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

Advertising by Adpathway

Bristol Myers Squibb’s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma.

The post Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma appeared first on MedCity News.

Read Entire Article

Start the new Vibrations with a Medbed Franchise today!

Protect your whole family with Quantum Orgo-Life® devices

Advertising by Adpathway